Companies / Eikon Therapeutics, Inc.
Eikon Therapeutics, Inc.
Nasdaq: EIKNCIK 1861123MILLBRAE, CA
Ownership
54.1M shares outstanding · as of May 1, 2026
Ownership
| Insiders | 4.97% | 2,690,621 |
| 10%+ / strategic | 17.35% | 9,393,779 |
| Institutions | 16.57% | 8,968,923 |
| Public float | 61.11% | 33,085,305 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 31
View all →| Insider | % of shares | Shares |
|---|---|---|
The Column Group IV GP, LP10% owner | 10.68% | 5,780,143 |
Lux Venture Partners V, LLC10% owner | 4.24% | 2,294,653 |
Wolfe JoshDirector · 10% owner | 4.24% | 2,294,653 |
Foresite Capital Management IV, LLC10% owner | 2.44% | 1,318,983 |
Perlmutter Roger MSee remarks · Director | 0.53% | 284,857 |
Frazier Kenneth CDirector | 0.21% | 111,111 |
Baynes Roy D.Chief Medical Officer | — | — |
Bowie Alfred Lloyd Jr.Chief Financial Officer | — | — |
Chen LeonDirector | — | — |
Column Group IV-A, LP10% owner | — | — |
Institutional holders 12
View all →| Holder | Value | % of shares |
|---|---|---|
| $55.87M | 7.91% | |
| $21.75M | 3.08% | |
| $10.81M | 1.89% | |
| $5.88M | 1.03% | |
| $4.62M | 0.65% | |
| $4.01M | 0.70% | |
| $2.90M | 0.51% | |
| $1.86M | 0.32% | |
| $1.78M | 0.31% | |
| $603.8K | 0.11% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 6, 2026 | The Column Group IV GP, LP 10% owner | Buy | Common Stock | $25.87M | +1.4M +50.00% | 4,312,139 7.96% of shares | high |
| Feb 6, 2026 | The Column Group IV GP, LP 10% owner | Buy | Common Stock | $11.36M | +631K +91.66% | 1,319,164 2.44% of shares | high |
| Feb 4, 2026 | Wolfe Josh Director | Buy | Common Stock | $2.50M | +139K | 138,888 0.26% of shares | high |
| Feb 4, 2026 | Wolfe Josh Director | Buy | Common Stock | $2.50M | +139K | 138,888 0.26% of shares | high |
| Feb 4, 2026 | Lux Venture Partners V, LLC 10% owner | Buy | Common Stock | $2.50M | +139K | 138,888 0.26% of shares | high |
| Feb 4, 2026 | Lux Venture Partners V, LLC 10% owner | Buy | Common Stock | $2.50M | +139K | 138,888 0.26% of shares | high |
| Feb 4, 2026 | Frazier Kenneth C Director | Buy | Common Stock | $2.00M | +111K | 111,111 0.21% of shares | high |
| Feb 4, 2026 | Foresite Capital Management IV, LLC 10% owner | Buy | Common Stock | $1000.0K | +56K +4.40% | 1,318,983 2.44% of shares | high |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Abu Dhabi Investment Authority | Passive13G | — |
| Foresite Capital Fund IV, L.P. | Passive13G | — |
| Perlmutter Roger M | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| EIKN | — | 282564103 |